A vaccine for pancreatic cancer? Penn In the News Deutsche Welle A vaccine for pancreatic cancer? Drew Weissman of the Perelman School of Medicine comments on the efficacy of a potential pancreatic cancer vaccine. Pancreatic cancer vaccine shows promise in small initial trial Penn In the News Scientific American Pancreatic cancer vaccine shows promise in small initial trial Drew Weissman of the Perelman School of Medicine is supportive of findings about a pancreatic cancer vaccine, though he says larger studies are needed to determine effectiveness. Why Penn research powers many FDA-approved treatments On August 30, 2017, faculty and staff at the Perelman Center for Advanced Medicine gathered for a “flash mob” celebration of the the FDA approval of a Penn Medicine-developed personalized cellular immune therapy. (Image: Courtesy of Penn Medicine News) Why Penn research powers many FDA-approved treatments Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications. Targeted prenatal therapy addresses long-standing gap in health equity Image: iStock/Motortion Targeted prenatal therapy addresses long-standing gap in health equity Penn engineers have developed a successful delivery system of mRNA to placental cells to treat preeclampsia at its root. New mRNA vaccine to fight 20 known subtypes of influenza Image: Bernard Chantal for Adobe Stock New mRNA vaccine to fight 20 known subtypes of influenza Heading into clinical trials, the new research from Penn Medicine may serve as a general preventative measure against future flu pandemics. Behind the scenes in the lab and the future of mRNA research Behind the scenes in the lab and the future of mRNA research Developing new vaccines and novel mRNA delivery methods, coupled with the satisfaction of mentoring and selfless dedication to medicine, inspire the work of scientists at the Weissman Lab. University of Pennsylvania’s first NFT commemorates mRNA research A still image from the 3D animated video component of the non-fungible token, which will also include patent documents and a letter from Drew Weissman of Penn Medicine. (Image: Courtesy Penn Medicine and Christie’s) University of Pennsylvania’s first NFT commemorates mRNA research Proceeds from the July auction of the non-fungible token—a digital asset—will benefit ongoing research at Penn. From a pandemic, scientific insights poised to impact more than just COVID-19 Bijels, or bicontinuous interfacially jammed emulsion gels, are structured emulsions of oil and water that are kept separated by a layer of nanoparticles. Penn Engineering researchers will develop a way of using them to manufacture mRNA-based therapeutics. (Image: Penn Engineering Today) From a pandemic, scientific insights poised to impact more than just COVID-19 Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges. Vaccine-like mRNA injection can be used to make CAR T cells in the body Vaccine-like mRNA injection can be used to make CAR T cells in the body An experimental immunotherapy can temporarily reprogram patients’ immune cells to attack heart fibroblast cells via only a single injection of mRNA. From foundational discoveries to profound impact Today, Weissman and colleagues are working to develop a pan-coronavirus vaccine capable of protecting the population against SARS, MERS, SARS-CoV-2, and more. At BioNTech, Karikó is overseeing parallel but distinct research on a range of diseases in which patients receive mRNA encoding therapeutic proteins. (Image: Peggy Peterson) From foundational discoveries to profound impact How decades of mRNA research at Penn made powerful new COVID-19 vaccines possible—and opened a new vista for future discoveries. Load More
Pancreatic cancer vaccine shows promise in small initial trial Penn In the News Scientific American Pancreatic cancer vaccine shows promise in small initial trial Drew Weissman of the Perelman School of Medicine is supportive of findings about a pancreatic cancer vaccine, though he says larger studies are needed to determine effectiveness. Why Penn research powers many FDA-approved treatments On August 30, 2017, faculty and staff at the Perelman Center for Advanced Medicine gathered for a “flash mob” celebration of the the FDA approval of a Penn Medicine-developed personalized cellular immune therapy. (Image: Courtesy of Penn Medicine News) Why Penn research powers many FDA-approved treatments Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications. Targeted prenatal therapy addresses long-standing gap in health equity Image: iStock/Motortion Targeted prenatal therapy addresses long-standing gap in health equity Penn engineers have developed a successful delivery system of mRNA to placental cells to treat preeclampsia at its root. New mRNA vaccine to fight 20 known subtypes of influenza Image: Bernard Chantal for Adobe Stock New mRNA vaccine to fight 20 known subtypes of influenza Heading into clinical trials, the new research from Penn Medicine may serve as a general preventative measure against future flu pandemics. Behind the scenes in the lab and the future of mRNA research Behind the scenes in the lab and the future of mRNA research Developing new vaccines and novel mRNA delivery methods, coupled with the satisfaction of mentoring and selfless dedication to medicine, inspire the work of scientists at the Weissman Lab. University of Pennsylvania’s first NFT commemorates mRNA research A still image from the 3D animated video component of the non-fungible token, which will also include patent documents and a letter from Drew Weissman of Penn Medicine. (Image: Courtesy Penn Medicine and Christie’s) University of Pennsylvania’s first NFT commemorates mRNA research Proceeds from the July auction of the non-fungible token—a digital asset—will benefit ongoing research at Penn. From a pandemic, scientific insights poised to impact more than just COVID-19 Bijels, or bicontinuous interfacially jammed emulsion gels, are structured emulsions of oil and water that are kept separated by a layer of nanoparticles. Penn Engineering researchers will develop a way of using them to manufacture mRNA-based therapeutics. (Image: Penn Engineering Today) From a pandemic, scientific insights poised to impact more than just COVID-19 Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges. Vaccine-like mRNA injection can be used to make CAR T cells in the body Vaccine-like mRNA injection can be used to make CAR T cells in the body An experimental immunotherapy can temporarily reprogram patients’ immune cells to attack heart fibroblast cells via only a single injection of mRNA. From foundational discoveries to profound impact Today, Weissman and colleagues are working to develop a pan-coronavirus vaccine capable of protecting the population against SARS, MERS, SARS-CoV-2, and more. At BioNTech, Karikó is overseeing parallel but distinct research on a range of diseases in which patients receive mRNA encoding therapeutic proteins. (Image: Peggy Peterson) From foundational discoveries to profound impact How decades of mRNA research at Penn made powerful new COVID-19 vaccines possible—and opened a new vista for future discoveries.
Why Penn research powers many FDA-approved treatments On August 30, 2017, faculty and staff at the Perelman Center for Advanced Medicine gathered for a “flash mob” celebration of the the FDA approval of a Penn Medicine-developed personalized cellular immune therapy. (Image: Courtesy of Penn Medicine News) Why Penn research powers many FDA-approved treatments Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications.
Targeted prenatal therapy addresses long-standing gap in health equity Image: iStock/Motortion Targeted prenatal therapy addresses long-standing gap in health equity Penn engineers have developed a successful delivery system of mRNA to placental cells to treat preeclampsia at its root.
New mRNA vaccine to fight 20 known subtypes of influenza Image: Bernard Chantal for Adobe Stock New mRNA vaccine to fight 20 known subtypes of influenza Heading into clinical trials, the new research from Penn Medicine may serve as a general preventative measure against future flu pandemics.
Behind the scenes in the lab and the future of mRNA research Behind the scenes in the lab and the future of mRNA research Developing new vaccines and novel mRNA delivery methods, coupled with the satisfaction of mentoring and selfless dedication to medicine, inspire the work of scientists at the Weissman Lab.
University of Pennsylvania’s first NFT commemorates mRNA research A still image from the 3D animated video component of the non-fungible token, which will also include patent documents and a letter from Drew Weissman of Penn Medicine. (Image: Courtesy Penn Medicine and Christie’s) University of Pennsylvania’s first NFT commemorates mRNA research Proceeds from the July auction of the non-fungible token—a digital asset—will benefit ongoing research at Penn.
From a pandemic, scientific insights poised to impact more than just COVID-19 Bijels, or bicontinuous interfacially jammed emulsion gels, are structured emulsions of oil and water that are kept separated by a layer of nanoparticles. Penn Engineering researchers will develop a way of using them to manufacture mRNA-based therapeutics. (Image: Penn Engineering Today) From a pandemic, scientific insights poised to impact more than just COVID-19 Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges.
Vaccine-like mRNA injection can be used to make CAR T cells in the body Vaccine-like mRNA injection can be used to make CAR T cells in the body An experimental immunotherapy can temporarily reprogram patients’ immune cells to attack heart fibroblast cells via only a single injection of mRNA.
From foundational discoveries to profound impact Today, Weissman and colleagues are working to develop a pan-coronavirus vaccine capable of protecting the population against SARS, MERS, SARS-CoV-2, and more. At BioNTech, Karikó is overseeing parallel but distinct research on a range of diseases in which patients receive mRNA encoding therapeutic proteins. (Image: Peggy Peterson) From foundational discoveries to profound impact How decades of mRNA research at Penn made powerful new COVID-19 vaccines possible—and opened a new vista for future discoveries.